Amarin | AMRN - Credores Comerciais





Credores Comerciais Alterar Data
AbbVie USD 33.3B 29.71B 2026-06
Alnylam Pharmaceuticals USD 135.4M 27.38M 2026-09
Amarin USD 40.43M 21.63M 2026-09
AstraZeneca USD 23.57B 679M 2026-09
BioCryst Pharmaceuticals USD 14.58M 3.12M 2026-09
DBV Technologies USD 13.8M 25.7M 2026-09
GlaxoSmithKline GBP 15.63B 1.29B 2026-09
Halozyme Therapeutics USD 33.55M 9.94M 2026-09
Heron Therapeutics USD 8.38M 3.27M 2026-09
Ionis Pharmaceuticals USD 27.11M 20.59M 2026-09
Nektar Therapeutics USD 10.03M 744K 2026-03
Neurocrine Biosciences USD 754.1M 612.1M 2026-09
Novartis USD 4.24B 15M 2026-09